Latest filing published 27 Aug 2026 for ANI Pharmaceuticals INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Henry O. Gosebruch, listed as board member, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in AbbVie Inc., ACELYRIN, Inc. and Neumora Therapeutics, Inc. The record holds 12 filings, for trades running from 7 September 2021 to 19 August 2026.
Market trades split into 2 purchases (€998k) and 2 sales (€4.1M). On balance, insiders were net sellers of €3.1M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 4 share grants and 2 option exercises.
On 27 August 2026 came the latest disclosure, a share grant in ANI Pharmaceuticals Inc. The latest purchase dates back some time: it was published 1,125 days ago, on 19 September 2023. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations